Research Topics
| L AnnemansSummaryAffiliation: Ghent University Country: Belgium Publications
| Collaborators
|
Detail Information
Publications
A cost-utility analysis of pregabalin in the management of peripheral neuropathic painL Annemans
IMS Health, De Crayerstraat 6, 1000 Brussel, Belgium
Acta Clin Belg 63:170-8. 2008..To assess the cost per QALY (quality-adjusted life years) of pregabalin in the management of peripheral neuropathic pain...
Which patients should receive aspirin for primary prevention of cardiovascular disease? An economic evaluationL Annemans
Department of Public Health, Faculty of Medicine, Ghent University, Ghent, Belgium
Int J Clin Pract 60:1129-37. 2006..In conclusion, low-dose aspirin treatment becomes cost-saving at a very low 10-year risk of fatal CVD. The cost of gastrointestinal bleeding defines the level at which low-dose aspirin becomes cost-saving...
A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarctionMark Lamotte
HEDM-IMS, Bruxelles, Belgium
Herz 31:74-82. 2006..Adding highly concentrated n-3 PUFAs to standard treatment in the secondary prevention after MI appears to be cost-effective in the 5 countries studied...
The impact of treatment with risperidone long-acting injection on the Belgian healthcare system: results from a budget impact modelL Annemans
Ghent University and Brussels University VUB, Belgium
Acta Clin Belg 67:108-19. 2012..This report indicates that improvements in adherence and long-term outcomes previously demonstrated for RLAI treatment in Belgium may result in substantial cost benefits to the country's healthcare system...
Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic reviewNick Verhaeghe
Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185 B 9000 Ghent, Belgium
Int J Behav Nutr Phys Act 8:28. 2011..Special attention was given if any of the included studies in the review also examined the cost-effectiveness of these health promotion interventions...
Deriving reference values and utilities for the QoL-AGHDA in adult GHDJ J V Busschbach
Medical Psychology and Psychotherapy, Erasmus MC, P O Box 2040, 3000 CA, Rotterdam, The Netherlands
Eur J Health Econ 12:243-52. 2011..Ideally, for use in health economics, QoL should be expressed in utilities. The aim of this study was to obtain reference values and utilities for QoL of GHD in adults in Belgium and the Netherlands...
The equity dimension in evaluations of the quality and outcomes framework: a systematic reviewPauline Boeckxstaens
Department of Family Medicine, Ghent University, Belgium
BMC Health Serv Res 11:209. 2011..In this evaluation, a theory-based framework conceptualising equity in terms of equal access, equal treatment and equal treatment outcomes for people in equal need is used to guide the work...
The ties that bind: an integrative framework of physician-hospital alignmentJeroen Trybou
Department of Public Health, Ghent University, Belgium
BMC Health Serv Res 11:36. 2011..The second approach, noneconomic integration, represents a sociological perspective emphasizing the cooperative nature of their relationship...
Systematic review: Effects, design choices, and context of pay-for-performance in health carePieter Van Herck
Center for Health Services and Nursing Research, Katholieke Universiteit Leuven, Kapucijnenvoer 35, 3000 Leuven, Belgium
BMC Health Serv Res 10:247. 2010..Effect domains include clinical effectiveness, access and equity, coordination and continuity, patient-centeredness, and cost-effectiveness...
Methodological issues in evaluating cost effectiveness of adjuvant aromatase inhibitors in early breast cancer: a need for improved modelling to aid decision makingLieven Annemans
Department of Public Health, Ghent University, Ghent, Belgium
Pharmacoeconomics 26:409-23. 2008..A list of key features (related to time horizon, clinical data input, patient subtypes, budget impact and model calibration) that an ideal model should have in order to better assist decision makers in this field is proposed...
Cost-effectiveness of cetuximab in combination with irinotecan compared with current care in metastatic colorectal cancer after failure on irinotecan--a Belgian analysisL Annemans
Ghent University, Belgium
Acta Clin Belg 62:419-25. 2007..In conclusion, cetuximab plus irinotecan for patients with metastatic CRC, after failure on irinotecan-containing chemotherapy, is rather cost-effective compared with current care in both scenarios tested...
Health economic evaluation of controlled and maintained physical exercise in the prevention of cardiovascular and other prosperity diseasesLieven Annemans
Ghent University, Ghent, Belgium
Eur J Cardiovasc Prev Rehabil 14:815-24. 2007..Given the scarce resources that can be spent on health and health care, the objective of this study was to evaluate the long-term health and economic outcomes of controlled and maintained physical exercise in a fitness setting...
Health economic evaluation of ferucarbotran-enhanced MRI in the diagnosis of liver metastases in colorectal cancer patientsLieven Annemans
HEDM, Brussels, Belgium
Int J Colorectal Dis 23:77-83. 2008..The objective of our study was to analyze the health economic impact of ferucarbotran-enhanced magnetic resonance imaging (MRI) in the diagnosis of hepatic colorectal cancer metastases based on observed changes in medical management...
Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantationL Annemans
Ghent University, Ghent, Belgium
Transplant Proc 39:3306-12. 2007..The cost-effectiveness of everolimus and MMF versus azathioprine was assessed to 6 months posttransplantation...
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005L Annemans
Ghent University, Faculty of Medicine, Department of Public Health, Ghent, Belgium
Ann Rheum Dis 67:960-6. 2008..To investigate and compare the prevalence, comorbidities and management of gout in practice in the UK and Germany...
Cost-effectiveness analysis of aprepitant in the prevention of chemotherapy-induced nausea and vomiting in BelgiumLieven Annemans
Ghent University, De Pintelaan 185, 9000, Gent, Belgium
Support Care Cancer 16:905-15. 2008..We assessed the cost effectiveness of aprepitant-based vs standard prevention in these indications in Belgium...
[Is long-term use of clopidogrel cost-effective in high-risk atherothrombotic patients?]L Annemans
Département d Economie de la Santé, Universiteit Gent
Rev Med Brux 30:11-22. 2009..Sensitivity analyses varying life expectancy, efficacy of clopidogrel, costs of events and cost of adverse events and discount rates demonstrated the robustness of the results...
Pharmacoeconomic impact of adverse events of long-term opioid treatment for the management of persistent painLieven Annemans
Ghent University, Ghent, and Brussels University, VUB, Brussels, Belgium
Clin Drug Investig 31:73-86. 2011..For this reason, the adverse-event profile of opioid-based analgesics should be improved to achieve more efficient long-term pain control...
Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinomaLieven Annemans
Faculty of Medicine, University of Ghent, De Pintelaan 185, Ghent, Belgium
Eur J Dermatol 18:539-46. 2008..Costs calculated from this study confirm predicted cost-effectiveness in the original model for MAL-PDT in the management of AK and BCC...
Societal and patient burden of fibromyalgia syndromeLieven Annemans
Faculty of Medicine, Ghent University Hospital, Ghent, Belgium
Pharmacoeconomics 27:547-59. 2009..Despite the complex and controversial construct of this syndrome, the results in terms of patient, healthcare payer and societal burden are quite consistent...
Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysisLieven Annemans
Department of Public Health, Universiteit Gent, Gent, Belgium
Clin Drug Investig 29:655-65. 2009....
A health economic model to assess the cost-effectiveness of PEG IFN alpha-2a and ribavirin in patients with mild chronic hepatitis CS Gerkens
Universite Catholique de Louvain, Cliniques Universitaires Saint Luc, Brussels, Belgium
J Viral Hepat 14:523-36. 2007....
Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trialE Mehuys
Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Belgium
J Clin Pharm Ther 36:602-13. 2011..It is also not known how sustainable any observed effects on glycaemic control are, over time. This study was initiated to address both these issues...
Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinomaK Caekelbergh
HEDM (Health Economics and Disease Management, Brussels, Belgium
Br J Dermatol 155:784-90. 2006..50 per day of response, and that MAL-PDT is better value for money than excision in BCC, taking a 5-year time horizon...
Estimating resource use and cost of prophylactic management of neutropenia with filgrastimL Annemans
HEDM, Meise, Belgium
J Nurs Manag 13:265-74. 2005..77 Euros for a patient without febrile neutropenia, excluding drug costs. With the activity-based costing method it is possible to accurately demonstrate cost savings in the management of neutropenia using the newer drug therapies...
Cost effectiveness of atorvastatin in patients with type 2 diabetes mellitus: a pharmacoeconomic analysis of the collaborative atorvastatin diabetes study in the belgian populationL Annemans
Department of Public Health, Ghent University, Ghent, Belgium
Clin Drug Investig 30:133-42. 2010..This study aimed to estimate the cost effectiveness in the Belgian setting of atorvastatin 10 mg compared with no treatment for the primary prevention of CV events in type 2 diabetes patients without a history of CV disease...
Effectiveness of pharmacist intervention for asthma control improvementE Mehuys
Pharmaceutical Care Unit Ghent, Faculty of Pharmaceutical Sciences, Ghent University Hospital, Ghent, Belgium
Eur Respir J 31:790-9. 2008..In conclusion, pragmatic community pharmacy-based programmes can significantly improve therapeutic outcomes in adult asthma patients...
Cost-effectiveness of anastrozole compared to tamoxifen in hormone receptor-positive early breast cancer. Analysis based on the ATAC trialK Moeremans
Health Economics and Disease Management, Brussels, Belgium and Public Health Department, Ghent University, Ghent, Belgium
Int J Gynecol Cancer 16:576-8. 2006..In conclusion, provided that a sufficient time horizon is taken and that long-term model predictions are confirmed from further follow-up from the ATAC study, anastrozole is a highly cost-effective adjuvant therapy compared to tamoxifen...
Assessment of the economic value of the INTERCEPT blood system in BelgiumK Moeremans
HEDM, Health Economics and Disease Management, Brussels, Belgium
Transfus Med 16:17-30. 2006..3 million Euro per lifeyear), IBSP can be considered cost-effective, taking into account the potential risk of emerging pathogens...
Health economic consequences related to the diagnosis of fibromyalgia syndromeL Annemans
IMS Health, Brussels, Ghent University, Ghent, Belgium
Arthritis Rheum 58:895-902. 2008..To evaluate the use and costs of medical resources before and after a diagnosis of fibromyalgia syndrome (FMS) in a large primary care population in the UK...
Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in BelgiumL Annemans
Department of Public Health, Ghent University, Ghent, Belgium
Acta Clin Belg 59:346-57. 2004....
A health economic model to assess the long term effects and cost-effectiveness of PEG IFN alpha-2a in hepatitis C virus infected patientsL Annemans
HEDM, Meise, Belgium
Acta Gastroenterol Belg 67:1-8. 2004..The objectives of this study were to estimate the long-term clinical consequences of such treatment as well as the resulting cost-effectiveness...
Medication use and disease management of type 2 diabetes in BelgiumEls Mehuys
Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Harelbekestraat 72, Gent 9000, Belgium
Pharm World Sci 30:51-6. 2008..Diabetes Care 2006;29:S4-42) to propose these services as a pharmacist intervention...
Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in BelgiumLieven Annemans
Department of Public Health, Ghent University, Ghent, Belgium
Pharmacoeconomics 27:231-45. 2009....
Psychological well-being and socio-economic hardship among AIDS orphans and other vulnerable children in GuineaWim Delva
International Centre for Reproductive Health, Ghent University, Ghent, Belgium
AIDS Care 21:1490-8. 2009..This situation calls for sustainable and holistic approaches to ensure the psychological and socio-economic stability of AIDS orphans and other vulnerable children...
Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infectionsStijn I Blot
Intensive Care Department, Ghent University Hospital, Ghent, Belgium
Clin Infect Dis 41:1591-8. 2005..We evaluate clinical and economic outcomes associated with nosocomial central venous catheter-related bloodstream infection (CR-BSI) in intensive care unit (ICU) patients...
Health economic evaluation of treating anemia in cancer patients receiving chemotherapy: a study in Belgian hospitalsErik Spaepen
IMS Health, Brussels, Belgium
Oncologist 13:596-607. 2008..This retrospective database study compared the three currently available ESAs, epoetin alfa (EPO-A), epoetin beta (EPO-B), and darbepoetin alfa (DARB), regarding costs and outcomes...
Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infectionDominique M Vandijck
Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185, Ghent, Belgium
Int J Antimicrob Agents 31:161-5. 2008..The antibiotic cost associated with ICU-acquired, laboratory-confirmed BSI is significant and should be reduced by implementing infection control measures and preventive strategies...
Quality of life after intensive care: a systematic review of the literatureSandra G Oeyen
Department of Intensive Care Medicine, Ghent University Hospital, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium
Crit Care Med 38:2386-400. 2010....
A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular diseaseMark Lamotte
Health Economics and Disease Management, Brussels, Belgium
Pharmacoeconomics 24:155-69. 2006..The primary objective of this study was to assess the economic consequences of the use of low-dose aspirin in the primary prevention of CVD in four European countries (UK, Germany, Spain and Italy)...
Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in BelgiumL Annemans
Ghent University, Ghent, Belgium
J Med Econ 13:537-51. 2010..To determine the cost-effectiveness of vaccination against herpes zoster (HZ) and post-herpetic neuralgia (PHN) in individuals aged 60 years and older in Belgium...
A novel multidisciplinary educational programme for patients with chronic skin diseases: Ghent pilot project and first resultsJ Lambert
Department of Dermatology, Ghent University Hospital, Belgium
Arch Dermatol Res 303:57-63. 2011..These positive initial results are stimulating to set up a prospective controlled randomised trial investigating the impact on quality of life, the clinical efficacy and the cost-effectiveness of this educational intervention programme...
Injury rate and socioeconomic costs resulting from sports injuries in Flanders: data derived from sports insurance statistics 2003E Cumps
Department of Human Physiology and Sports Medicine, Vrije Universiteit Brussel, Pleinlaan 2 B 1050, Brussels, Belgium
Br J Sports Med 42:767-72. 2008..This study determines the injury rate (%) and the associated direct medical and indirect costs of sports injuries in Flanders...
Economic evaluation of Campral (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patientsL Annemans
Vrije Universiteit Brussel, Brussels, Belgium
Eur Addict Res 6:71-8. 2000..A global anticipated net saving of 70 million BEF (1.74 million Euro) over 2 years was estimated for the Belgian health insurance...
Economic evaluation of intravenous itraconazole for presumed systemic fungal infections in neutropenic patients in KoreaK Moeremans
HEDM, Health Economics and Disease Management, Brussels, Belgium
Int J Hematol 82:251-8. 2005..Compared with current treatment with CAB, IVitra therapy was shown to be a cost-effective and cost-saving empirical treatment for PSFI in neutropenic cancer patients and BMT patients...
Voriconazole treatment of invasive aspergillosis: real-world versus health-economic model resultsHilde Van Campenhout
Medical Department Pfizer, Brussels, Belgium
Clin Drug Investig 28:509-21. 2008....
Medication use and disease control of asthmatic patients in Flanders: a cross-sectional community pharmacy studyE Mehuys
Pharmaceutical Care Unit Ghent, Faculty of Pharmaceutical Sciences, Ghent University, Department of Respiratory Diseases, Ghent University Hospital, Harelbekestraat 72, 9000 Ghent, Belgium
Respir Med 100:1407-14. 2006..9% of the patients. In conclusion, the ACT appears to be a useful tool to determine rapidly and accurately the level of asthma control in patients presenting at community pharmacies...
Long-term medical costs of postmenopausal breast cancer therapyV Cocquyt
Department of Medical Oncology, University Hospital, Ghent, Belgium
Ann Oncol 14:1057-63. 2003..From a health economic point of view, one is interested in the costs saved by disease prevention...
An update: health economics of managing multiple myelomaK Moeremans
HEDM, a unit of IMSHealth, Crayerstraat 6, 1000 Brussels, Belgium
Eur J Cancer 42:1684-91. 2006..There is also a clear need for peer reviewed economic evaluations of novel therapies such as thalidomide and Bortezomib in the treatment of multiple myeloma at different stages of the disease...
Cost effectiveness of long-acting risperidone: what can pharmacoeconomic models teach us?Lieven Annemans
Department of Public Health, Ghent University, and HEDM, IMS Health, Brussels, Belgium
Pharmacoeconomics 23:1-2. 2005
A health economic evaluation of concomitant surgical ablation for atrial fibrillationMark Lamotte
IMS Health Economics and Outcomes Research, Brussels, Belgium
Eur J Cardiothorac Surg 32:702-10. 2007..g. CABG, valve repair) in comparison with non-interventional (drug) treatment...
Perceptions of mental health nurses and patients about health promotion in mental health care: a literature reviewN Verhaeghe
Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium
J Psychiatr Ment Health Nurs 18:487-92. 2011..Despite the awareness of the importance of health promotion in mental health care, it appears that visions and attitudes towards the potential of health promotion are in need of change...
Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in BelgiumLieven Annemans
Ghent University, Ghent, Belgium
J Med Econ 11:135-50. 2008..Human papillomavirus (HPV) infections can lead to cervical intraepithelial neoplasia (CIN) lesions, cervical cancer (CC) and genital warts (GWs). This study intended to assess the annual cost of CC, CIN and GW management in Belgium...
The economic impact of using alfuzosin 10 mg once daily in the management of acute urinary retention in the UK: a 6-month analysisLieven Annemans
Department of Public Health, Ghent University, Ghent, Belgium
BJU Int 96:566-71. 2005..To calculate the economic consequences of using alfuzosin 10 mg once daily for managing acute urinary retention (AUR) related to benign prostatic hyperplasia (BPH)...
A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarctionMark Lamotte
Health Economics and Outcomes Research, Unit of IMS Health, Brussels, Belgium
Pharmacoeconomics 24:783-95. 2006..This study assessed the cost effectiveness of adding n-3 PUFAs to the current secondary prevention treatment versus standard prevention alone after acute MI in five countries: Australia, Belgium, Canada, Germany and Poland...
An Asian regional analysis of cost-effectiveness of early irbesartan treatment versus conventional antihypertensive, late amlodipine, and late irbesartan treatments in patients with type 2 diabetes, hypertension, and nephropathyLieven Annemans
Ghent University and IMS Health, Bruxelles, Belgium, and IMS Health, Bruxelles, Belgium
Value Health 11:354-64. 2008..This treatment has proven to be cost-effective in Western countries. This study assessed the cost-effectiveness of early irbesartan treatment in Asian settings...
Thinking ahead--the rising tide of AIDS orphansWim Delva
Department of Family Medicine and Primary Health Care, Ghent University, Ghent, Belgium
S Afr Med J 95:656-8. 2005
Critical appraisal of scientific posters comparing anemia treatments for cancer patients: applying ISPOR Task Force guidelines on methodological quality of retrospective studiesNadia Demarteau
IMS Health, Brussels, Belgium
Crit Rev Oncol Hematol 63:91-9. 2007..The ISPOR guidelines for the evaluation of retrospective analyses are a useful tool for assessing the quality of scientific posters...
Health economic evaluation of liver MRI in colorectal cancer patientsThomas Helmberger
Institute of Clinical Radiology, University of Munich, Marchioninistrasse 15, , Germany
Eur Radiol 14:C13. 2004
An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settingsAndrew J Palmer
Center for Outcomes Research, St Johanns Ring 139, CH 4056 Basel, Switzerland
Nephrol Dial Transplant 18:2059-66. 2003..A simulation model was developed to project long-term cost consequences of the IDNT in Belgium and France...
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysisPatrick Haentjens
Department of Orthopaedics and Traumatology, Academisch Ziekenhuis, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
Arch Orthop Trauma Surg 124:507-17. 2004..Whether implementing routine prolonged prophylaxis is cost-effective remains uncertain...
The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathyRoger A Rodby
Rush Presbyterian St Luke s Medical Center, Chicago, Illinois, USA
Clin Ther 25:2102-19. 2003..End-stage renal disease (ESRD)-related health care costs are substantial. Improving clinical outcomes in patients at risk of progression to ESRD could lead to considerable health care savings...
Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseasesJasper M Bos
Groningen University Institute for Drug Exploration, University of Groningen, Groningen, The Netherlands
Pharmacoeconomics 22:1171-9. 2004..A numerical example illustrates our approach. We discuss the associated potential implications for public health policy and discuss how the effects of the intervention can be additionally corrected for societal preferences...
What reimbursement for coronary revascularization with drug-eluting stents?Rosanna Tarricone
CeRGAS SDA Bocconi University, Milan, Italy
Eur J Health Econ 5:309-16. 2004..SES is thus a cost-saving strategy in the perspective of the SSN that could therefore support the introduction of the new technology by reimbursing about 80% of its current incremental acquisition cost...
A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patientsMark Lamotte
Health Economics and Disease Management, Brusselsteenweg 91, B-1860 Meise, Belgium
Diabetes Care 25:303-8. 2002..Evidence on longer-term benefits of orlistat (>2 years) will be of importance for future decision-making...
A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in BelgiumKoen Demyttenaere
Department of Psychiatry, University Hospital Gasthuisberg, Leuven, Belgium
Clin Ther 27:111-24. 2005..The success rates were similar between venlafaxine and escitalopram, but higher total costs were observed with venlafaxine...
A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertensionAndrew J Palmer
CORE Center for Outcomes Research, Allschwil Basel, Switzerland
Curr Med Res Opin 22:2095-100. 2006..We performed a cost-consequence analysis in a French setting of the renoprotective benefit of irbesartan in hypertensive type 2 diabetes patients over a 25-year period...
Economic burden of pertussis and the impact of immunizationJ Jaime Caro
Caro Research Institute, Concord, MA 01742, USA
Pediatr Infect Dis J 24:S48-54. 2005..Despite the existing gaps in data, further research using the most current data should facilitate decisions on new vaccination strategies by describing conditions for favorable results and quantifying the margin of uncertainty...
[Health economic evaluation of low-dose acetylsalicylic acid in the primary prevention of cardiovascular disease]Mark Lamotte
Rev Esp Cardiol 59:807-15. 2006..Administering low-dose aspirin to individuals with a 10-year risk of coronary heart disease > or =15% would result in significant cost savings for the Spanish NHS. Sensitivity analysis confirmed the robustness of these findings...
A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in JapanKiichiro Tsutani
The Department of Pharmacoeconomics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan
Intern Med 46:157-62. 2007..This study assessed the health economic consequences of the use of low-dose aspirin in the primary prevention of CVD in Japan...
European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatmentLazzaro Repetto
Istituto Nazionale di Riposo e Cura per Anziani, Unita Operativa di Oncologia, Via Cassia 1167, Rome 00189, Italy
Cancer Treat Rev 32:S5-9. 2006..Treatment of anaemia with ESAs is cost-effective and is associated with long-term gains in quality-adjusted life years...
Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patienAndrew J Palmer
CORE Center for Outcomes Research, Buendtenmattstrasse 40, 4102 Binningen Basel, Switzerland
Diabetes Care 27:1897-903. 2004..The aim of this study was to determine the most cost-effective time point for initiation of irbesartan treatment in hypertensive patients with type 2 diabetes and renal disease...
A health economic model to assess the cost-effectiveness of pegylated interferon alpha-2a and ribavirin in patients with moderate chronic hepatitis C and persistently normal alanine aminotransferase levelsSophie Gerkens
Universite Catholique de Louvain, Cliniques Universitaires Saint Luc, Bruxelles, Belgium
Acta Gastroenterol Belg 70:177-87. 2007..The objective of this study was to estimate the cost-effectiveness of their treatment in comparison with no treatment...
Discounting health effects in pharmacoeconomic evaluations: current controversiesJ M Bos
Groningen, University Institute for Drug Exploration, Department of Social Pharmacy, Pharmacoepidemiology, Groningen, The Netherlands
Pharmacoeconomics 23:639-49. 2005..Instead, results should be presented in a non-aggregated manner that enables policy makers to value health gains according to timing and to which subpopulation they are accrued in...
[Cost-effectiveness of darbepoetin alpha in an every-3-weeks schedule]Isabelle Borget
Service d études et de recherche en économie de la santé, Institut Gustave Roussy, Villejuif
Bull Cancer 95:465-73. 2008..The Q3W schedule is cost saving compare to the QW schedule. It also reduces the burden of the frequent visits for the patients...
How to improve screening in first-degree relatives of patients with premature coronary heart diseaseLieve Debruyne
Department of Public Health, Ghent University, University Hospital, Ghent, Belgium
Eur J Cardiovasc Prev Rehabil 13:711-7. 2006..This is the first and necessary step to improve the management of risk factors in these people, who are at increased risk for CHD...
Recommended structure for reporting economic evaluation on pharmaceuticals in BelgiumLieven Annemans
UZ GENT Centrale Apotheek, De Pintelaan 185, 9000 Gent
Pharm World Sci 24:5-7. 2002..Standard Report Format can support the quality, transparency and exhaustiveness of the data submitted. A multidisciplinary task force developed a Standard Report Format for pharmaco-economic evaluations in Belgium...
Modeling costs and cost-effectiveness of different CMV management strategies in liver transplant recipients as a support for current and future decision makingLieven Annemans
Health Economics and Disease Management Meise, Belgium
Value Health 5:347-58. 2002..To develop a generic decision-analytic model to predict health and economic outcomes of different management options for cytomegalovirus (CMV) infection and disease in liver transplant patients...
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysisJosephine A Mauskopf
RTI Health Solutions, Research Triangle Park, NC, USA
Value Health 10:336-47. 2007..The objective of this report is to present guidance on methodologies for those undertaking such analyses or for those reviewing the results of such analyses...
Cost-effectiveness analysis of bicalutamide (Casodex) for adjuvant treatment of early prostate cancerKaren Moeremans
Health Economics and Disease Management, Meise, Belgium
Value Health 7:472-81. 2004..CONCLUSION: Based on the current data, bicalutamide appears to be a cost-effective option for adjuvant treatment of EPC...
Education in pharmacoeconomics: an international multidisciplinary viewKaren L Rascati
College of Pharmacy, The University of Texas, Austin, Texas 78712, USA
Pharmacoeconomics 22:139-47. 2004..This method can improve the standardisation of the educational process; however, there is still much work to be done in order to achieve real consensus on 'learning outcomes' in pharmacoeconomics...
Economic evaluations in healthcare: comments on a recent articleLieven Annemans
Reprod Biomed Online 11:786. 2005
Long-acting methylphenidate-OROS in youths with attention-deficit hyperactivity disorder suboptimally controlled with immediate-release methylphenidate: a study of cost effectiveness in The NetherlandsAdrianne Faber
Groningen University Institute for Drug Exploration, University of Groningen, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen, The Netherlands
CNS Drugs 22:157-70. 2008..Stimulants are the drugs of first choice in the treatment of ADHD. It has been suggested that full costs associated with the treatment of ADHD may be reduced by once-daily administration regimens of stimulants...
